A variety of signaling pathways are involved in the pathogenesis of DLBCL including those involving the B-cell receptor (BCR), NFκB, NOTCH, Toll-like receptor (TLR), PI3 kinase, MAP kinase, immunity, cell cycle/apoptosis, and chromatin modification [3,5–7]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.